IN VIVO ANTIBODIES FROM BIO X CELL
New bispecific antibody from Bio X Cell: InVivoSIM anti-human CD3 x BCMA
We are excited to introduce a new bispecific antibody from Bio X Cell: InVivoSIM anti-human CD3 x BCMA
What makes a bispecific antibody ready for in vivo research? Purity. Consistency. Functional validation. Built for translational success, this bispecific antibody engages CD3+ T cells and BCMA+ tumor cells—supporting BiTE therapy research in myeloma models.
- In vivo-grade, carrier-free formulation
- Clinically relevant format
- Validated for reliable preclinical performance
Explore more on the next generation of bispecifics.
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.
ABOUT BIO X CELL
Antibodies For In Vivo Research
Bio X Cell antibodies are formulated for in vivo experiments and used extensively in animal models of human disease. They feature greater than 95% purity, ultra-low endotoxin levels, and are presevative, stabilizer, and carrier protein-free. Bio X Cell has developed a wide range of antibodies for immuno-oncology, immunology, and neuroscience research. Their products are cited in over 15,000 publications that detail a broad range of applications, including in vivo cell-specific depletion, cytokine neutralization, immune checkpoint blockade, and more.
-
- Exceptional Purity
- Pathogen Free
- Ultra-low Endotoxin Level
- Advanced Binding Validation
- Low Protein Aggregation
- Marching Isotype Control Antibodies
All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.